The introduction of nicotinamide to be a nicotine substitution in e-cigarette and smokeless items represents a major regulatory problem to the FDA. Nicotinamide does not have nicotinic receptor agonist activity and is thought to act as a sedative at high dosages6. The statements created by Nicotine River, ECBlend, together with other vendors that t